{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:43:55Z","timestamp":1794224635138,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ampullary cancer represents approximately 6% of the malignant periampullary tumors. An early occurrence of symptoms leads to a 5-year survival rate after curative surgery of 30 to 67%. In addition to the tumor stage, the immunohistological subtypes appear to be important for postoperative prognosis. The aim of this study was to analyze the different subtypes regarding their prognostic relevance. A total of 170 patients with ampullary cancer were retrospectively analyzed between 1999 until 2016 after pancreatic resection. Patients were grouped according to their pathohistological subtype of ampullary cancer (pancreatobiliary, intestinal, mixed). Characteristics among the groups were analyzed using univariate and multivariate models. Survival probability was analyzed by the Kaplan-Meier method. An exact subtyping was possible in 119 patients. A pancreatobiliary subtype was diagnosed in 69 patients (58%), intestinal in 41 patients (34.5%), and a mixed subtype in 9 patients (7.6%). Survival analysis showed a significantly worse 5-year survival rate for the pancreatobiliary subtype compared with the intestinal subtype (27.5% versus 61%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The mean overall survival of patients with pancreatobiliary, intestinal, and mixed subtype was 52.5, 115 and 94.7 months, respectively (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The pathohistological subtypes of ampullary cancer allows a prediction of the postoperative prognosis.<\/jats:p>","DOI":"10.1038\/s41598-019-49179-w","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T10:08:04Z","timestamp":1567505284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Carolin","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieder","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Detlev","family":"Saeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Ehehalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Welsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"49179_CR1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jamcollsurg.2008.01.028","volume":"207","author":"JT Carter","year":"2008","unstructured":"Carter, J. T., Grenert, J. P., Rubenstein, L., Stewart, L. & Way, L. W. Tumors of the ampulla of vater: histopathologic classification and predictors of survival. Journal of the American College of Surgeons 207, 210\u2013218 (2008).","journal-title":"Journal of the American College of Surgeons"},{"key":"49179_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1245\/s10434-012-2603-0","volume":"20","author":"A Westgaard","year":"2013","unstructured":"Westgaard, A., Pomianowska, E., Clausen, O. P. & Gladhaug, I. P. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies? Annals of surgical oncology 20, 430\u2013439 (2013).","journal-title":"Annals of surgical oncology"},{"key":"49179_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00000658-199807000-00013","volume":"228","author":"JR Howe","year":"1998","unstructured":"Howe, J. R., Klimstra, D. S., Moccia, R. D., Conlon, K. C. & Brennan, M. F. Factors predictive of survival in ampullary carcinoma. Annals of surgery 228, 87\u201394 (1998).","journal-title":"Annals of surgery"},{"key":"49179_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/jso.22090","volume":"105","author":"WS Kim","year":"2012","unstructured":"Kim, W. S. et al. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer. Journal of surgical oncology 105, 266\u2013272 (2012).","journal-title":"Journal of surgical oncology"},{"key":"49179_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jso.21374","volume":"100","author":"J Albores-Saavedra","year":"2009","unstructured":"Albores-Saavedra, J., Schwartz, A. M., Batich, K. & Henson, D. E. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. Journal of surgical oncology 100, 598\u2013605 (2009).","journal-title":"Journal of surgical oncology"},{"key":"49179_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jamcollsurg.2005.08.002","volume":"202","author":"RD Kim","year":"2006","unstructured":"Kim, R. D. et al. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 202, 112\u2013119 (2006).","journal-title":"J Am Coll Surg"},{"key":"49179_CR7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/bjs.10563","volume":"104","author":"A Acharya","year":"2017","unstructured":"Acharya, A. et al. Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma. The British journal of surgery 104, 814\u2013822 (2017).","journal-title":"The British journal of surgery"},{"key":"49179_CR8","unstructured":"Albores-Saavedra, J., Henson, D. E., Klimstra, D. S., (US), A. F. I. o. P. & Pathology, U. A. f. R. a. E. i. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater\/by Jorge Albores-Saavedra, Donald Earl Henson, and David S. Klimstra., (Washington, D.C.: Armed Forces Institute of Pathology., 2000)."},{"key":"49179_CR9","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/1097-0142(19880401)61:7<1394::AID-CNCR2820610720>3.0.CO;2-M","volume":"61","author":"W Kimura","year":"1988","unstructured":"Kimura, W. & Ohtsubo, K. Incidence, sites of origin, and immunohistochemical and histochemical characteristics of atypical epithelium and minute carcinoma of the papilla of Vater. Cancer 61, 1394\u20131402 (1988).","journal-title":"Cancer"},{"key":"49179_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00000478-200407000-00005","volume":"28","author":"H Zhou","year":"2004","unstructured":"Zhou, H., Schaefer, N., Wolff, M. & Fischer, H. P. Carcinoma of the ampulla of Vater: comparative histologic\/immunohistochemical classification and follow-up. Am J Surg Pathol 28, 875\u2013882 (2004).","journal-title":"Am J Surg Pathol"},{"key":"49179_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1349-7006.1994.tb02077.x","volume":"85","author":"W Kimura","year":"1994","unstructured":"Kimura, W. et al. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res 85, 161\u2013166 (1994).","journal-title":"Jpn J Cancer Res"},{"key":"49179_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00534-004-0894-7","volume":"11","author":"W Kimura","year":"2004","unstructured":"Kimura, W., Futakawa, N. & Zhao, B. Neoplastic diseases of the papilla of Vater. J Hepatobiliary Pancreat Surg 11, 223\u2013231 (2004).","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"49179_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0046-8177(85)80018-6","volume":"16","author":"K Baczako","year":"1985","unstructured":"Baczako, K., Buchler, M., Beger, H. G., Kirkpatrick, C. J. & Haferkamp, O. Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma. Hum Pathol 16, 305\u2013310 (1985).","journal-title":"Hum Pathol"},{"key":"49179_CR14","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/1097-0142(19880401)61:7<1403::AID-CNCR2820610721>3.0.CO;2-S","volume":"61","author":"JP Neoptolemos","year":"1988","unstructured":"Neoptolemos, J. P., Talbot, I. C., Shaw, D. C. & Carr-Locke, D. L. Long-term survival after resection of ampullary carcinoma is associated independently with tumor grade and a new staging classification that assesses local invasiveness. Cancer 61, 1403\u20131407 (1988).","journal-title":"Cancer"},{"key":"49179_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","volume":"38","author":"DC Ang","year":"2014","unstructured":"Ang, D. C., Shia, J., Tang, L. H., Katabi, N. & Klimstra, D. S. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater. The American journal of surgical pathology 38, 1371\u20131379 (2014).","journal-title":"The American journal of surgical pathology"},{"key":"49179_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/jso.24274","volume":"114","author":"E Asano","year":"2016","unstructured":"Asano, E. et al. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma. Journal of surgical oncology 114, 119\u2013127 (2016).","journal-title":"Journal of surgical oncology"},{"key":"49179_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1365-2559.2001.01244.x","volume":"39","author":"S Cross","year":"2001","unstructured":"Cross, S. Tumors of the Gallbladder, Extrahepatic Biliary Ducts, and Ampulla of Vater. Histopathology 39, 432 (2001).","journal-title":"Histopathology"},{"key":"49179_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-170","volume":"8","author":"A Westgaard","year":"2008","unstructured":"Westgaard, A. et al. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer 8, 170 (2008).","journal-title":"BMC Cancer"},{"key":"49179_CR19","doi-asserted-by":"publisher","first-page":"e65144","DOI":"10.1371\/journal.pone.0065144","volume":"8","author":"MJ Overman","year":"2013","unstructured":"Overman, M. J. et al. Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome. PLoS One 8, e65144 (2013).","journal-title":"PLoS One"},{"key":"49179_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-428","volume":"13","author":"P Bronsert","year":"2013","unstructured":"Bronsert, P. et al. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin. BMC Cancer 13, 428 (2013).","journal-title":"BMC Cancer"},{"key":"49179_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/SLA.0b013e318287ab73","volume":"258","author":"M Distler","year":"2013","unstructured":"Distler, M. et al. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Annals of surgery 258, 324\u2013330 (2013).","journal-title":"Annals of surgery"},{"key":"49179_CR22","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","volume":"31","author":"DK Chang","year":"2013","unstructured":"Chang, D. K. et al. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. J Clin Oncol 31, 1348\u20131356 (2013).","journal-title":"J Clin Oncol"},{"key":"49179_CR23","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/SLA.0000000000001808","volume":"265","author":"P Nitschke","year":"2017","unstructured":"Nitschke, P. et al. Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic Cancer: A Single-center Experience With 483 Patients. Annals of surgery 265, 1219\u20131225 (2017).","journal-title":"Annals of surgery"},{"key":"49179_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archsurg.134.5.526","volume":"134","author":"HG Beger","year":"1999","unstructured":"Beger, H. G. et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 134, 526\u2013532 (1999).","journal-title":"Arch Surg"},{"issue":"5","key":"49179_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/00000658-199705000-00015","volume":"225","author":"Mark A. Talamini","year":"1997","unstructured":"Talamini, M. A. et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 225, 590\u2013599; discussion 599\u2013600 (1997).","journal-title":"Annals of Surgery"},{"key":"49179_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MPA.0000000000001194","volume":"48","author":"C Luchini","year":"2019","unstructured":"Luchini, C. et al. Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis. Pancreas 48, 70\u201376 (2019).","journal-title":"Pancreas"},{"key":"49179_CR27","first-page":"1641","volume":"54","author":"YH Roh","year":"2007","unstructured":"Roh, Y. H. et al. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis. Hepato-gastroenterology 54, 1641\u20131644 (2007).","journal-title":"Hepato-gastroenterology"},{"key":"49179_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1309\/AJCPCTCUQSYI89YT","volume":"135","author":"I Kohler","year":"2011","unstructured":"Kohler, I. et al. Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications. Am J Clin Pathol 135, 202\u2013211 (2011).","journal-title":"Am J Clin Pathol"},{"key":"49179_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08165-w","volume":"7","author":"S Hempel","year":"2017","unstructured":"Hempel, S. et al. Para-aortic lymph node metastases in pancreatic cancer should not be considered a watershed for curative resection. Sci Rep 7, 7688 (2017).","journal-title":"Sci Rep"},{"key":"49179_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/jso.23600","volume":"110","author":"K Okano","year":"2014","unstructured":"Okano, K. et al. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma. J Surg Oncol 110, 156\u2013162 (2014).","journal-title":"J Surg Oncol"},{"key":"49179_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF00422939","volume":"70","author":"D Basso","year":"1992","unstructured":"Basso, D. et al. Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis. The Clinical investigator 70, 49\u201354 (1992).","journal-title":"The Clinical investigator"},{"issue":"Suppl 4","key":"49179_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/annonc\/10.suppl_4.S145","volume":"10","author":"R Lamerz","year":"1999","unstructured":"Lamerz, R. Role of tumour markers, cytogenetics. Annals of oncology: official journal of the European Society for Medical Oncology 10(Suppl 4), 145\u2013149 (1999).","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"key":"49179_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/jama.1975.03260040020016","volume":"233","author":"BB Lurie","year":"1975","unstructured":"Lurie, B. B., Loewenstein, M. S. & Zamcheck, N. Elevated carcinoembryonic antigen levels and biliary tract obstruction. Jama 233, 326\u2013330 (1975).","journal-title":"Jama"},{"key":"49179_CR34","first-page":"350","volume":"85","author":"W Steinberg","year":"1990","unstructured":"Steinberg, W. The clinical utility of the CA 19-9 tumor-associated antigen. The American journal of gastroenterology 85, 350\u2013355 (1990).","journal-title":"The American journal of gastroenterology"},{"key":"49179_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ijrobp.2006.04.018","volume":"66","author":"S Bhatia","year":"2006","unstructured":"Bhatia, S., Miller, R. C., Haddock, M. G., Donohue, J. H. & Krishnan, S. Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 66, 514\u2013519 (2006).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"49179_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-6-126","volume":"6","author":"AK Narang","year":"2011","unstructured":"Narang, A. K. et al. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Radiat Oncol 6, 126 (2011).","journal-title":"Radiat Oncol"},{"key":"49179_CR37","doi-asserted-by":"crossref","unstructured":"Nassour, I. et al. Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract (2017).","DOI":"10.1007\/s11605-017-3624-6"},{"key":"49179_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2012.7352","volume":"308","author":"JP Neoptolemos","year":"2012","unstructured":"Neoptolemos, J. P. et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308, 147\u2013156 (2012).","journal-title":"JAMA"},{"key":"49179_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.surg.2015.02.001","volume":"158","author":"TS Schiergens","year":"2015","unstructured":"Schiergens, T. S. et al. Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater. Surgery 158, 151\u2013161 (2015).","journal-title":"Surgery"},{"key":"49179_CR40","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3109\/00365521.2011.610006","volume":"46","author":"S Amptoulach","year":"2011","unstructured":"Amptoulach, S., Josefsson, A., Kavantzas, N. & Kalaitzakis, E. Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter? Scand J Gastroenterol 46, 1401\u20131403 (2011).","journal-title":"Scand J Gastroenterol"},{"key":"49179_CR41","unstructured":"Sobin, L. H., Gospodarowicz, M. & Wittekind, C. 336 (Blackwell Publishing Ltd, November 2009)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49179-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49179-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49179-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:13:55Z","timestamp":1671282835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49179-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49179"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49179-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12676"}}